Biopool Posts 10% Gain in Income for 1st Quarter

Biopool International Inc. in Ventura reported $3.9 million in sales for the first quarter of 1999, compared with $3.8 million for the same period one year ago.

Net income rose 10%, from $182,000 in 1998’s first quarter to $201,000 this year. Earnings per share remained at 2 cents for both periods.

“Overall, our financial results improved this quarter compared to quarterly results throughout 1998,” said Michael D. Bick, chairman and chief executive.

“Reported results for this quarter include the results of operations of our BCA business, which was sold effective April 30.”

Bick said second-quarter results also will contain certain revenues and expenses from the discontinued BCA operations.

“The third quarter and beyond will reflect the return of Biopool to a pure-play hemostasis company, which has historically been our most profitable activity,” he said.

Biopool manufactures test kits to assess and diagnose blood disorders, as well as specialty toxicology controls used to monitor and measure the presence of drugs. The company’s products are sold to hospitals, clinical laboratories, commercial reference laboratories and research institutions.